Published in Cell Host Microbe on November 12, 2014
Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host Microbe (2016) 1.25
Long noncoding RNAs in innate immunity. Cell Mol Immunol (2015) 0.85
Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C. Clin Exp Med (2016) 0.83
Long noncoding RNAs in B-cell development and activation. Blood (2016) 0.82
Flavivirus sfRNA suppresses antiviral RNA interference in cultured cells and mosquitoes and directly interacts with the RNAi machinery. Virology (2015) 0.82
Induction of innate immunity and its perturbation by influenza viruses. Protein Cell (2015) 0.82
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus. J Prev Med Hyg (2014) 0.81
Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication. EMBO Rep (2016) 0.80
Microarray analysis of long noncoding RNA and mRNA expression profiles in human macrophages infected with Mycobacterium tuberculosis. Sci Rep (2016) 0.80
Emerging role of long noncoding RNAs as regulators of innate immune cell development and inflammatory gene expression. Eur J Immunol (2016) 0.79
Functional diversity of long non-coding RNAs in immune regulation. Genes Dis (2016) 0.79
Functional prediction of differentially expressed lncRNAs in HSV-1 infected human foreskin fibroblasts. Virol J (2016) 0.79
HULC: an oncogenic long non-coding RNA in human cancer. J Cell Mol Med (2016) 0.79
Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells. Sci Rep (2016) 0.78
Long noncoding RNAs in viral infections. Virus Res (2015) 0.78
Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol (2017) 0.77
eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants. Oncotarget (2016) 0.77
Landscape of post-transcriptional gene regulation during hepatitis C virus infection. Curr Opin Virol (2015) 0.77
Robust expression of vault RNAs induced by influenza A virus plays a critical role in suppression of PKR-mediated innate immunity. Nucleic Acids Res (2015) 0.77
Identification of cancer risk lncRNAs and cancer risk pathways regulated by cancer risk lncRNAs based on genome sequencing data in human cancers. Sci Rep (2016) 0.76
The Long Noncoding RNA NEAT1 Exerts Antihantaviral Effects by Acting as Positive Feedback for RIG-I Signaling. J Virol (2017) 0.76
Avian Tembusu virus infection effectively triggers host innate immune response through MDA5 and TLR3-dependent signaling pathways. Vet Res (2016) 0.76
lncRNA-mediated regulation of the interferon response. Virus Res (2015) 0.75
LncRNAs and immunity: watchdogs for host pathogen interactions. Biol Proced Online (2017) 0.75
Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression. Proc Natl Acad Sci U S A (2016) 0.75
Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome. Sci Rep (2016) 0.75
lncRHOXF1, a Long Noncoding RNA from the X Chromosome That Suppresses Viral Response Genes during Development of the Early Human Placenta. Mol Cell Biol (2016) 0.75
Understanding of leukemic stem cells and their clinical implications. Mol Cancer (2017) 0.75
Involvement of Host Non-Coding RNAs in the Pathogenesis of the Influenza Virus. Int J Mol Sci (2016) 0.75
Interferon-Induced Transmembrane Protein 3 Inhibits Hantaan Virus Infection, and Its Single Nucleotide Polymorphism rs12252 Influences the Severity of Hemorrhagic Fever with Renal Syndrome. Front Immunol (2017) 0.75
Microarray Analysis Identifies the Potential Role of Long Non-Coding RNA in Regulating Neuroinflammation during Japanese Encephalitis Virus Infection. Front Immunol (2017) 0.75
Long Non-coding RNAs in Hepatitis C Virus-Infected Cells. Front Microbiol (2017) 0.75